Share

Regeneron launches US clinical trials to treat severe COVID-19 symptoms

Biotech giant Regeneron will test an arthritis drug on COVID-19 patients that could reduce the need for venitilators, Chief Scientific Officer Dr. George Yancopoulos told CNBC's Jim Cramer.
02:33
Wed, Mar 18 20202:25 PM EDT